Psychopharmacology and Clinical Application of Aripiprazole Long Acting Injections – Review of Abilify Maintena & Aristada
Aripiprazole long-acting injections (LAIs) come in two forms – Abilify Maintena and Aristada. This article covers the psychopharmacology of Aripiprazole LAIs.
Antipsychotic nonadherence is common in schizophrenia with rates high (44% to 75%) across all stages of the disease, from patients with first-episode psychosis to patients with chronic schizophrenia. [Robinson et al, 1999], [Agid et al, 2010] Therefore, there is considerable interest in transitioning patients from oral medication to long-acting injectable (LAI) antipsychotics. This is also particularly true in psychotic patients who are in remission.